Princeton, NJ (PRWEB) November 26, 2013
IntegriChain Executive Vice President Josh Halpern will be speaking today at CBI’s 9th Annual Trade and Channel Strategies show in Philadelphia on the topic of Daily Business Management – how pharmaceutical companies and their trade partners can align their mutual interests through data-driven collaboration.
In today’s era of Fee for Service agreements and reduced channel inventory, pharmaceutical manufacturers continue to search for ways that their trade teams, the brands they service, and their trade partners can balance product availability with the overall cost of distribution. Through the utilization of trade data, companies can engage trade partners in more proactive partnership to avoid service level issues and ensure that products are available when and where they are needed.
Josh Halpern co-founded IntegriChain in 2007. Its premier solution, Demand Network Analytics (DNA), is an informed application cloud used by suppliers to manage buyer relationships, orders, and inventories. DNA is a collaborative and agile alternative to ERP and home-grown systems that enables suppliers to increase sales and get more out of their distribution investment.
“The trend today is increasingly away from same day product availability, which contradicts what many brand teams still expect,” says Halpern. “This requires a reset of expectations and education on the benefits of Daily Business Management. Trade data can be very powerful when used in a collaborative model for sustaining a high quality of FDC service in a direct to store delivery model.”
For more information on the complete DNA solution offering, please visit http://www.integrichain.com.